Article in mSphere, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors at 1 institution in 1 country.
Emily M SmithCenter for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA.ORCID 0000-0002-3312-833X
Antonia PapadimasCenter for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA.
Caitlin GaborCenter for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA.
Ceanna CooneyCenter for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA.
Tao WuCenter for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA.
David RaskoInstitute for Genome Sciences, University of Maryland School of Medicine , Baltimore, Maryland, USA.
Eileen M BarryCenter for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA.ORCID 0000-0002-5326-0047
University of Maryland, Baltimore · US
Funding
Project 3 - Human colonoids as a model for the pathobiology of EHECP01AI125181 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI KAPER, JAMES B · 2016 to 2025
$18.6M
Probiotic yeast secreting single-domain antibodies to prevent Clostridium difficile and Campylobacter jejuni diseaseU19AI142725 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI SZTEIN, MARCELO B. · 2019 to 2023
$12.5M
Systems-Level Research in Microbial PathogenesisT32AI162579 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI NICHOLAS H CARBONETTI, Julie Dunning Hotopp · 2022 to 2026
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
The role of the minor colonization factor CS14 in adherence to intestinal cell models by geographically diverse ETEC isolates. · full record | OpenQuestion